662 Statistical learning from clinical and immunogenomic variables to predict response and survival with PD-L1 inhibition in advanced urothelial cancer
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1818562695131037696 |
|---|---|
| author | Benjamin Vincent Wolfgang Beck Tracy Rose Matthew Milowsky William Kim Jeff Klomp |
| author_facet | Benjamin Vincent Wolfgang Beck Tracy Rose Matthew Milowsky William Kim Jeff Klomp |
| author_sort | Benjamin Vincent |
| collection | DOAJ |
| first_indexed | 2024-12-14T01:07:08Z |
| format | Article |
| id | doaj.art-f70609ee579b4863b4e348c2fb441993 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-12-14T01:07:08Z |
| publishDate | 2020-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-f70609ee579b4863b4e348c2fb4419932022-12-21T23:22:57ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-11-018Suppl 310.1136/jitc-2020-SITC2020.0662662 Statistical learning from clinical and immunogenomic variables to predict response and survival with PD-L1 inhibition in advanced urothelial cancerBenjamin Vincent0Wolfgang Beck1Tracy Rose2Matthew Milowsky3William Kim4Jeff Klomp519University of North Carolina, Chapel Hill, NC, USAUNC-Chapel Hill, Chapel Hill, NC, USAUNC-Chapel Hill, Chapel Hill, NC, USAUNC-Chapel Hill, Chapel Hill, NC, USAUNC-Chapel Hill, Chapel Hill, NC, USAUNC-Chapel Hill, Chapel Hill, NC, USA |
| spellingShingle | Benjamin Vincent Wolfgang Beck Tracy Rose Matthew Milowsky William Kim Jeff Klomp 662 Statistical learning from clinical and immunogenomic variables to predict response and survival with PD-L1 inhibition in advanced urothelial cancer Journal for ImmunoTherapy of Cancer |
| title | 662 Statistical learning from clinical and immunogenomic variables to predict response and survival with PD-L1 inhibition in advanced urothelial cancer |
| title_full | 662 Statistical learning from clinical and immunogenomic variables to predict response and survival with PD-L1 inhibition in advanced urothelial cancer |
| title_fullStr | 662 Statistical learning from clinical and immunogenomic variables to predict response and survival with PD-L1 inhibition in advanced urothelial cancer |
| title_full_unstemmed | 662 Statistical learning from clinical and immunogenomic variables to predict response and survival with PD-L1 inhibition in advanced urothelial cancer |
| title_short | 662 Statistical learning from clinical and immunogenomic variables to predict response and survival with PD-L1 inhibition in advanced urothelial cancer |
| title_sort | 662 statistical learning from clinical and immunogenomic variables to predict response and survival with pd l1 inhibition in advanced urothelial cancer |
| work_keys_str_mv | AT benjaminvincent 662statisticallearningfromclinicalandimmunogenomicvariablestopredictresponseandsurvivalwithpdl1inhibitioninadvancedurothelialcancer AT wolfgangbeck 662statisticallearningfromclinicalandimmunogenomicvariablestopredictresponseandsurvivalwithpdl1inhibitioninadvancedurothelialcancer AT tracyrose 662statisticallearningfromclinicalandimmunogenomicvariablestopredictresponseandsurvivalwithpdl1inhibitioninadvancedurothelialcancer AT matthewmilowsky 662statisticallearningfromclinicalandimmunogenomicvariablestopredictresponseandsurvivalwithpdl1inhibitioninadvancedurothelialcancer AT williamkim 662statisticallearningfromclinicalandimmunogenomicvariablestopredictresponseandsurvivalwithpdl1inhibitioninadvancedurothelialcancer AT jeffklomp 662statisticallearningfromclinicalandimmunogenomicvariablestopredictresponseandsurvivalwithpdl1inhibitioninadvancedurothelialcancer |